Superworth

Integra Lifesciences PE ratio IART

Share price divided by earnings per share over the last twelve months, since 2011.

Today, Nov 2, 2026
80.1×
10-year median
46.3×
Against its 10-year history
84th
percentile: 0 is its lowest day, 100 its highest
10-year range
18.7× to 179×
Peer median
28.3×

Integra Lifesciences' PE ratio is 80.1× as of Nov 2, 2026: a share price of $13.61 against $0.17 of earnings per share over the last twelve months.

That is above its ten-year median of 46.3×, higher than on 84% of days in the last ten years.

Over that time it ranged from 18.7× in May 2023 to 179× in Jun 2020.

The median for 10 medical instruments and supplies stocks of a similar size is 28.3×.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far80.1×75.0×80.1×
2025n/m a value too high to mean anything
202466.5×33.2×82.9×
202336.0×18.7×36.9×
202227.2×21.4×34.1×
202126.4×24.7×103×
202096.9×65.2×179×
201985.0×44.8×90.2×
201844.8×44.8×88.6×
201778.5×34.3×82.8×
201642.5×37.5×42.5×
201548.8×46.4×61.4×
201458.0×50.6×58.0×
201349.3×22.6×50.0×
201233.3×17.2×48.5×
201121.7×20.4×26.5×

Against its peers

Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.

CompanyPE ratio
IARTIntegra Lifesciences80.1×
IRMDIradimed42.5×
BVSBioventus17.1×
STAAStaar Surgical356×
CDRECadre38.9×
EYENational Vision28.1×
MOVMovado17.7×
LMATLemaitre Vascular28.5×
INSPInspire Medical Systems14.5×
TCMDTactile Systems Technology21.2×
UFPTUFP Technologies30.6×
Peer median28.3×

Where Integra Lifesciences ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Integra Lifesciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.